Skip to main content
About
Our Mission
Threat of AMR
Access and Appropriate Use Principles
Our Investors
Team
Investments
How We Invest
Our Portfolio
Get On Our Radar
News
Connect
Enabling Breakthroughs in Antimicrobials
2 TO 4 NOVEL ANTIBIOTICS BY 2030
We Invest...
In biotechnology companies that are developing treatments for patients suffering from life-threatening antimicrobial-resistant infections.
Our investments
We Build...
Partnerships to create a sustainable innovation ecosystem so that new treatments continue evolving alongside the threat of AMR.
The Threat of AMR
We Advocate...
For market reforms and policy solutions that change how society values these lifesaving drugs.
Who we are
Connect With Us
Contact
